Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
British Journal of Community Nursing|November 2, 2006
Understanding and tackling fear of crime among older peopleAlan BurnettBritish Journal of Community Nursing|September 14, 2007
A call for greater flexibility in the use of public transportAlan BurnettClinical Lymphoma, Myeloma & Leukemia|March 11, 2020
AML: New Drugs but New ChallengesAlan Burnett, Richard StoneJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2011
Therapeutic advances in acute myeloid leukemiaAlan Burnett, Meir Wetzler, Bob LöwenbergCurrent Opinion in Oncology|August 18, 2009
FLT3 inhibition as a targeted therapy for acute myeloid leukemiaMiguel Sanz, Alan Burnett, Francesco Lo-Coco, et al.Haematologica|March 28, 2008
Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blastsElisabeth Walsby, Val Walsh, Chris Pepper, et al.Leukemia Research|December 15, 2010
Aminopeptidase inhibition by the novel agent CHR-2797 (tosedostat) for the therapy of acute myeloid leukemiaChristopher Jenkins, Saman Hewamana, David Krige, et al.British Journal of Haematology|December 14, 2021
Treatment intensification with FLAG-Ida may improve disease control in younger patients with secondary acute myeloid leukaemia: long-term follow up of the MRC AML15 trialNigel Russell, Robert Hills, Lars Kjeldsen, et al.British Journal of Haematology|November 28, 2008
Nuclear factor-kappaB as a potential therapeutic target for the novel cytotoxic agent LC-1 in acute myeloid leukaemiaChristopher Jenkins, Saman Hewamana, Amanda Gilkes, et al.Oncotarget|March 3, 2016
The targeted histone deacetylase inhibitor tefinostat (CHR-2845) shows selective in vitro efficacy in monocytoid-lineage leukaemiasJoanna Zabkiewicz, Marie Gilmour, Robert Hills, et al.Pageof 4